Topics

Latest "Improving Diabetic Foot Ulcers With Atorvastatin" News Stories

18:57 EST 12th November 2019 | BioPortfolio

Here are the most relevant search results for "Improving Diabetic Foot Ulcers With Atorvastatin" found in our extensive news archives from over 250 global news sources.

More Information about Improving Diabetic Foot Ulcers With Atorvastatin on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Improving Diabetic Foot Ulcers With Atorvastatin for you to read. Along with our medical data and news we also list Improving Diabetic Foot Ulcers With Atorvastatin Clinical Trials, which are updated daily. BioPortfolio also has a large database of Improving Diabetic Foot Ulcers With Atorvastatin Companies for you to search.

Showing "Improving Diabetic Foot Ulcers With Atorvastatin" News Articles 1–25 of 3,900+

Tuesday 12th November 2019

PolarityTE Reports Third Calendar Quarter 2019 Results

PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today reported financial results for the third calendar quarter of 2019. PolarityTE will host a conference call and webcast today, November 12, 2019 at 4:30pm ET. Please see details below. Highlights Total revenues were $1.395 million in Q3:19, an increase of ...


Stanford School of Medicine’s Carla Pugh to Keynote Healthcare Robotics Engineering Forum

Director of Stanford University School of Medicine’s Technology Enabled Clinical Improvement Center to discuss technology enabled clinical improvement at international event for developers of healthcare robotics solutions. Business-to-Business publisher WTWH Media announced that Carla Pugh, Professor of Surgery and Director of the Technology Enabl

2019 Diabetic Hypertension Clinical Trials Guide Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 [Report Updated: 24042019] Prices from USD $1799

The global clinical trial report 2019 Diabetic Hypertension Clinical Trials Study provides complete list of trials completed, ongoing and planned for Diabetic Hypertension. It presents indepth analysis of Diabetic Hypertension clinical trials across markets and companies. The research work is for providing complete understanding into trends in Diabetic Hypertension. The report covers a key snapsh...


Engineering Tailored Enzymes for Industrial Applications Using Codexis CodeEvolver® Technology, Upcoming Webinar Hosted by Xtalks

Directed evolution is a powerful technology that mimics the process of natural selection to guide protein engineering toward pre-defined, commercially-relevant objectives. In this free webinar, an expert from Codexis will provide an overview of directed evolution, and how Codexis applies it to improving enzymes for applications such as biotherapeutic discovery, the sustainable manufacture of pharm...

Aptinyx Begins Two Phase 2 Studies of NYX-2925

The company is evaluating its NYX-2925 treatment in painful diabetic peripheral neuropathy and fibromyalgia. The post Aptinyx Begins Two Phase 2 Studies of NYX-2925 appeared first on Investing News Network.

FHE Health Named “Primary Provider of Choice” by National Fraternal Order of Police

New Partnership Helps More Members of Law Enforcement and Their Families Access Quality Mental Health and Substance Abuse Treatment Thanks to a new partnership between the nationally recognized behavioral health provider FHE Health and the National Fraternal Order of Police (NFOP), thousands of police from around the country and their close loved ones now h

Humana again gets Gold award in American Heart Association’s Workplace Health Achievement Index

Recognition goes to companies with the best, evidence-based approaches to employee health and well-being and workplace culture For the third year in a row, Humana Inc. (NYSE: HUM) has achieved top Gold-level recognition in the American Heart Association’s Workplace Health Achievement Index, a science-based assessment that defines best practices and evaluates the quality, comprehensiveness and ...

Roche's pRED Leaders On Its Next Generation Of Drugs

"We're not resting on our laurels," pRED head William Pao said in an early R&D overview. The company's R&D leaders...    

Seed to Sale Cannabis Brand NUG Opens Second Custom-Design Retail Store, NUG Wellness, in San Leandro, CA

Space features dedicated Wellness Center focusing on CBD products and consumer education; Portion of proceeds donated to non-profit partner, Davis Street Family Resource Center NUG, one of the premier diversified cannabis companies in California, has opened a new flagship retail store, NUG Wellness, in San Leandro, California. As its name implies, NUG Wellness is poised to be a community hub for...

Longitudinal neovascular changes on optical coherence tomography angiography in proliferative diabetic retinopathy treated with panretinal photocoagulation alone versus with intravitreal conbercept plus panretinal photocoagulation: a pilot study

Novel dental informatics program to improve oral health for better overall health

With the goal of improving oral health for better overall physical and emotional health, Regenstrief Institute and Indiana University School of Dentistry are joining together to establish a novel dental informatics program.

Octane Trifecta™ Provides Health Clubs and Exercisers with New HIIT Experience

Launch of Octane Rō™ Enhances Indoor Rowing New Octane Trifecta™ gives exercisers and health clubs a unique collection of cardio machines that add variety and motivation to HIIT workouts, circuit routines and small group training Octane Trifecta accommodates exercisers of different levels with the new Octane Rō™ rower, the Octane Max Trainer® machine and the Octane AirdyneX™ bike...

Takara Bio Announces Launch of Human iPSC-derived Intestinal Epithelial Cells for Drug Discovery Research

Takara Bio USA, Inc. (TBUSA) announced that its parent company, Takara Bio Inc., has launched the world’s first commercially available small intestinal epithelial cells derived from human induced pluripotent stem cells. The new Cellartis® Intestinal Epithelial Cells (from

Couture Med Spa Releases Botox 101: Everything You Need to Know

The guide takes a look at some of the common misconceptions surrounding Botox as well as how it can be used safely and effectively. WINTER PARK, Fla. (PRWEB) November 12, 2019 Couture Med Spa has announced the release of their most recent infographic: Botox 101: Everything You Need to Know. The infographic breaks down common misconceptions about botox, how it works, and the benefits of botox, and...

MJH Life Sciences Acquires Element – The Data Agency

MJH Life Sciences™ (MJH), the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels, has acquired Element – The Data Agency. The firm is a leading provider of data-driven technology to support sales and marketing solutions in the animal and oral health markets. “The combination of ...

W. L. Gore & Associates To Reveal New Gender Insights From Real-world Aortic Data At 2019 VEITHsymposium

Four presentations will highlight data from one of the largest industry-sponsored registries of aortic stent grafts  W. L. Gore & Associates, Inc. (Gore) will share gender-focused real world aortic treatment insights during a lunch symposium at the 46th Annual VEITHsymposium in New York. The presentations will be facilitated by lead investigators of the Global Registry for Endovascular Aort...

Sheikh Shakhbout Medical City Opens in Abu Dhabi

The Stantec-designed, 3.2 million square-foot hospital is the most advanced healthcare facility in the United Arab Emirates The Sheikh Shakhbout Medical City (SSMC), one of the 10 largest hospitals in the United Arab Emirates (UAE), opened its doors recently, marking the completion of a 10-year, 3.2-million square foot project. Leading global design firm Stantec led the master planning, archite...

Risk Management in Medical Device Manufacturing, Upcoming Webinar Hosted by Xtalks

Medical device manufacturers operate in an increasingly regulated, safety-critical environment, and frequently have many variants of parts, products and product lines. It is, therefore, necessary to identify, estimate and evaluate your device risks at the right time to increase the quality and safety of the device, and to motivate the project members. Join this free webinar to learn about some tip...

Eswatini next to suspend South African animal imports after foot and mouth outbreak

ESwatini has suspended animal imports from neighboring South Africa for a second time this year following another outbreak of foot and mouth disease, the mountain kingdom's agricultural ministry said on Tuesday.

MOBILion Raises $15.4 Million in Series A Financing

MOBILion Systems, Inc., a life science company developing an advanced analytical instrument platform that efficiently identifies the most challenging molecules to accelerate biologic drug development and improve diagnostic insights, today announced they raised $15.4 million in Series A financing. The round was led by Agilent Technologies, with participation from IP Group Inc., Hostplus, Cultiva...

Boston Medical Centre to evaluate Motus GI’s Pure-Vu System

Motus GI has announced that the Boston Medical Centre (BMC), a non-profit academic medical centre, will conduct the EXPEDITE clinical study, to evaluate its Pure-Vu System for improving The post Boston Medical Centre to evaluate Motus GI’s Pure-Vu System appeared first on NS Medical Devices.

Aerie Pharmaceuticals to Present at the Stifel 2019 Healthcare Conference

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye today announced that Vicente Anido, Jr., Ph.D., Chairman and Chief Executive Officer, will present in a fireside discussion at t...

Why Companies in the Pharma Industry Need to Improve the Procurement Process? Read SpendEdge’s Article for Exhaustive Insights

SpendEdge, a leading provider of procurement market intelligence solutions, has announced the completion of their latest article on the imperative need of the procurement process in the pharma industry. This press release features multimedia. View the full release here:

SPH Analytics Announces Launch of IgniteMIPS Next Generation User Experience

Easier MIPS program management with enhanced financial impact analysis ALPHARETTA, Ga. (PRWEB) November 12, 2019 SPH Analytics (SPH), a leader in healthcare analytics and population health management, today announced the release of its new next generation user experience for IgniteMIPS™. Inspired by user feedback, the solution redesign offers an advanced, analytics-driven workflow which enable...

Merck’s Ervebo Becomes World’s First Approved Ebola Vaccine

Merck Sharp & Dohme will begin manufacturing licensed doses of Ervebo in Germany and will continue to send investigational vaccine...   


Quick Search

News Quicklinks